Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Aurora Spine Corporation
  6. News
  7. Summary
    ASG   CA05206X1087

AURORA SPINE CORPORATION

(ASG)
  Report
Delayed Bourse de Toronto  -  02:33:39 2023-02-07 pm EST
0.4500 CAD   +2.27%
2022Transcript : Aurora Spine Corporation, Q3 2022 Earnings Call, Nov 21, 2022
CI
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Aurora Spine Corp Announced Positive Interim Results from Clinical Study

10/27/2022 | 10:27am EST


ę MT Newswires 2022
All news about AURORA SPINE CORPORATION
2022Transcript : Aurora Spine Corporation, Q3 2022 Earnings Call, Nov 21, 2022
CI
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
GL
2022Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months..
CI
2022Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial ..
GL
2022Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial ..
GL
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using Z..
AQ
2022Aurora Spine Corp Announced Positive Interim Results from Clinical Study
MT
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study Using Z..
CI
2022Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using Z..
GL
More news
Financials (USD)
Sales 2021 10,5 M - -
Net income 2021 -2,36 M - -
Net cash 2021 0,63 M - -
P/E ratio 2021 -6,79x
Yield 2021 -
Capitalization 22,3 M 22,3 M -
EV / Sales 2020 2,10x
EV / Sales 2021 1,67x
Nbr of Employees -
Free-Float 80,7%
Chart AURORA SPINE CORPORATION
Duration : Period :
Aurora Spine Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Trent J. Northcutt President, CEO & Non-Independent Director
Chad Clouse Chief Financial Officer
David A. Rosenkrantz Chairman
Laszlo Garamszegi Chief Technology Officer
James Snow Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AURORA SPINE CORPORATION-1.10%22
ABBOTT LABORATORIES2.00%195 263
MEDTRONIC PLC11.40%115 167
BECTON, DICKINSON AND COMPANY-0.44%71 881
DEXCOM, INC.-3.30%42 295
HOYA CORPORATION11.92%38 588